Vertical transmission of hepatitis C virus: Systematic review and meta-analysis

Clinical Infectious Diseases

Volumn 59, Issue 6, 2014, Pages 765-773

  Benova, Lenka ^a,b   Mohamoud, Yousra A ^a   Calvert, Clara ^b   Abu Raddad, Laith J ^a,c,d  

^a Department of Obstetrics Gynecology   (Qatar)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Infant; Infectious disease transmission; Mother to child transmission; Pregnancy; Risk factors

Indexed keywords

ARTICLE; EMBASE; EXPOSURE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; META ANALYSIS; MIXED INFECTION; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; ADULT; FEMALE; GENETICS; HEPACIVIRUS; IMMUNOLOGY; INFANT; PREGNANCY; PRESCHOOL CHILD; RISK; TRANSMISSION;

ADULT; CHILD, PRESCHOOL; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; RISK; SEROEPIDEMIOLOGIC STUDIES;

EID: 84907384811     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu447     Document Type: Article

References (42)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41.
2. Mohd Hanafiah K, Groeger J, Flaxman AD,Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57:1333-42.
3. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36(5 suppl 1):S106-13.
4. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13:288.
5. Castro Sanchez AY, Aerts M, Shkedy Z, et al. A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective. Epidemics 2013; 5:56-66.
6. Resti M, Azzari C, Mannelli F, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317:437-41.
7. Mok J, Pembrey L, Tovo P-A, Newell M-L. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005; 90:F156-F60.
8. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment? J Viral Hepat 2011; 18:229-36.
9. Pembrey L, Newell ML, Tovo PA. The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 2005; 43:515-25.
10. Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 1997; 315:333-7.
11. Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998; 27:108-17.
12. Read JS, Cannon MJ, Stanberry LR, Schuval S. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008; 38:274-97.
13. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:1335-74.
14. Yeung LT, King SM, Roberts EA. Mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 34:223-9.
15. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol 2003; 32:727-34.
16. Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV co-infection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis 2007; 44:1123-31.
17. Resti M, Azzari C, Galli L, et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002; 185:567-72.
18. Azzari C, Moriondo M, Indolfi G, et al. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol 2008; 80:65-71.
19. European Paediatric Hepatitis C Virus Network. A significant sex - but not elective cesarean section - effect on mother-to-child transmission of hepatitis C Virus infection. J Infect Dis 2005; 192:1872-9.
20. Syriopoulou V, Nikolopoulou G, Daikos GL, et al. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis 2005; 37:350-3.
21. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192:1880-9.
22. Resti M, Bortolotti F, Azzari C, et al. Transmission of hepatitis C virus from infected mother to offspring during subsequent pregnancies. J Pediatr Gastroenterol Nutr 2000; 30:491-3.
23. Shiraki K, Ohto H, Inaba N, et al. Guidelines for care of pregnant women carrying hepatitis C virus and their infants. Pediatr Int 2008; 50:138-40.
24. Cottrell EB, Chou R,Wasson N, Rahman B, Guise JM. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Int Med 2013; 158:109-13.
25. Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet 2011; 283:255-60.
26. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
27. World Health Organization. Hepatitis C assays: operational characteristics (phase I). Geneva, Switzerland: WHO, Blood Safety and Clinical Technology, 2001.
28. Lin HH, Kao JH. Effectiveness of second- and third-generation immunoassays for the detection of hepatitis C virus infection in pregnant women. J Obstet Gynaecol Res 2000; 26:265-70.
29. Pembrey L, Tovo PA, Newell ML. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41:45-51.
30. Polywka S, Pembrey L, Tovo P-A, Newell M-L. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 2006; 78:305-10.
31. England K, Pembrey L, Tovo PA, et al. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 2005; 94:444-50.
32. Resti M, Bortolotti F, Vajro P, Maggiore G. Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. Dig Liver Dis 2003; 35:453-7.
33. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist 1950; 21:607-11.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Cont Clin Trials 1986; 7:177-88.
35. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
36. Lam JPH, McOmish F, Burns SM, Yap PL, Mok JYQ, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167:572-6.
37. Spencer JD, Latt N, Beeby PJ, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drugusing mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997; 4:395-409.
38. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009; 81:1024-31.
39. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in southern Tanzania. J Med Virol 1999; 58:215-20.
40. Feuth T, Arends JE, Fransen JH, et al. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One 2013; 8:e59302.
41. Lawitz E, Poordad FF, Pang PS, et al. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet 2013; 383:515-23.
42. Asselah T. Sofosbuvir for the treatment of hepatitis C virus. Expert Opin Pharmacother 2014; 15:121-30.